Breast Cancer’s Secret Weapon: CDK4/6 Inhibitors
Автор: OncologyTube
Загружено: 2024-12-17
Просмотров: 263
Описание:
In this engaging discussion, Dr. Paolo Tarantino delves into the transformative role of CDK4/6 inhibitors in managing HR+/HER2- early breast cancer. Learn about their impact on recurrence risks, real-world data from NATALEE and monarchE trials, and what it means for clinical practice.
🔍 Explore how these advancements are shaping outcomes for patients and uncover key insights into tolerability, eligibility, and long-term benefits. Don't miss this comprehensive breakdown of the latest updates in breast cancer research!
Chapters:
0:00 - Introduction to CDK4/6 Inhibitors in Breast Cancer
0:45 - Comparing Abemaciclib and Ribociclib: Eligibility and Benefits
2:00 - Recurrence Risks: Insights from Penelope B, monarchE, and NATALEE
3:10 - Long-Term Impact of Adjuvant CDK4/6 Inhibitors
4:30 - The Role of Biomarkers in Tailoring Treatments
5:20 - Real-World Data from the Flatiron Database
6:40 - Unmet Needs in HR+/HER2- Early Breast Cancer
7:20 - Clinical Implications and the Future of Breast Cancer Care
👩⚕️ Who should watch:
Oncologists, healthcare professionals, and anyone interested in the latest advancements in breast cancer treatment.
📈 Subscribe for more insights into groundbreaking cancer research!
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
